CSIMarket
 
Sensus Healthcare Inc  (NASDAQ: SRTS)
Other Ticker:  
 
 
Price: $6.1512 $-2.84 -31.577%
Day's High: $7 Week Perf: -25.3 %
Day's Low: $ 5.90 30 Day Perf: -15.04 %
Volume (M): 1,790 52 Wk High: $ 9.33
Volume (M$): $ 11,013 52 Wk Avg: $5.81
Open: $7.00 52 Wk Low: $2.91



 Market Capitalization (Millions $) 101
 Shares Outstanding (Millions) 16
 Employees 37
 Revenues (TTM) (Millions $) 33
 Net Income (TTM) (Millions $) 4
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 1

Sensus Healthcare Inc
Sensus Healthcare Inc is a medical device company that specializes in developing and delivering innovative and effective treatment solutions for non-melanoma skin cancers and other skin conditions. The company's flagship product, the SRT therapy, utilizes a low-energy X-ray technology called Superficial Radiation Therapy to provide non-invasive and painless treatment options for patients. Sensus Healthcare's focus is on providing safer, more cost-effective, and efficient treatments that improve patient outcomes and quality of life.


   Company Address: 851 Broken Sound Pkwy Boca Raton 33487 FL
   Company Phone Number: 922-5808   Stock Exchange / Ticker: NASDAQ SRTS


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ANIK        3.99% 
BDX   -8.26%    
BSX        2.58% 
CUTR        23.46% 
MDXG   -4.15%    
OSUR      0% 
• View Complete Report
   



Contract

Sensus Healthcare Expands Horizons in Oncology with Innovative SRT System Partnership

Published Wed, Sep 25 2024 12:01 PM UTC

In a notable move that underscores the growing impact of innovative technologies in oncology, Sensus Healthcare has secured a significant deal by selling its groundbreaking SRT (Superficial Radiation Therapy) System to Providence Swedish Hospital. This strategic partnership marks an exciting chapter not only for Sensus but also for the healthcare landscape in the treatment o...

Announcement

Revolutionary Radiotherapy for Furry Friends: Tel Aviv's Veterinary Emergency Hospital Takes a Giant Leap

Published Thu, May 9 2024 12:30 PM UTC

In a groundbreaking move for veterinary medicine, Tel Aviv s largest veterinary emergency hospital has acquired Sensus Healthcare s SRT-100, a state-of-the-art radiotherapy device traditionally used to treat cancer in humans. This marks the first veterinary commercial sale of the SRT-100 outside the United States, revolutionizing the way tumors in cats and dogs are treated. ...

Announcement

Sensus Healthcare to Discuss Promising First Quarter 2024 Financial Results and Business Update in Upcoming Conference Call

Published Thu, Apr 25 2024 12:01 PM UTC

Sensus Healthcare s First Quarter 2024 Financial Results Revealed: Promising Growth and Expanding Treatment SolutionsBOCA RATON, Fla., April 25, 2024 - Sensus Healthcare, Inc. (Nasdaq: SRTS), a leading medical device company specializing in innovative non-invasive treatments for both oncological and non-oncological conditions, announced that it will be holding a conference c...

Sensus Healthcare Inc

Sensus Healthcare Inc Faces Steep Reduction in Fiscal Q3 2023 - Revenue Drops by 56.737%

Financial healthcare company Sensus Healthcare Inc recently released its Sep 30 2023 report, which depicted disappointing results. The company's revenue decreased dramatically by -56.737% to $3.90 million compared to the same reporting period a year ago. Additionally, the net loss per share widened to $-0.09, contrasting with the net loss of $-0.02 per share in the preceding reporting season.
The Medical Equipment & Supplies sector, on the other hand, exhibited a positive trend in the third quarter of 2023. It observed a revenue rise of 4.83% compared to the third quarter of the previous year, demonstrating a contrasting performance to Sensus Healthcare Inc.

Sensus Healthcare Inc

Devastating Plunge: Sensus Healthcare Inc's Revenue Plummeted by a Shocking 62.525% in Second Quarter 2023

Sensus Healthcare Inc, a medical equipment and supplies company, recently announced its financial results for the span ending June 30, 2023. Unfortunately, the report revealed a disastrous performance, with a significant decline in revenue and an expanding shortfall per share.
Compared to the corresponding quarter a year before, Sensus Healthcare Inc experienced a staggering 62.525% decrease in revenue, reaching $4.53 million. This decline is not only concerning but also indicates a significant setback for the company. Additionally, the shortfall per share expanded to $-0.02, indicating that the company's financial difficulties have worsened compared to the previous year.







Sensus Healthcare Inc's Segments





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com